Summary
Receptor binding studies on rat cortical membranes were used to characterize the NMDA receptor in aged rats (22 months) treated for 20 months with a memantine containing diet delivering 30 mg/kg/day in comparison to aged and young/adult rats treated with control-diet. Spatial memory impairing effects of (+)-MK-801 (0.16 mg/kg) in the radial maze was not altered within the course of memantine-treatment (up to 16 months). However, chronic memantine-treatment significantly increased the number of [3H]MK-801 binding sites and the affinity of [3H]glycine. A non-significant trend to such changes was also seen in aged-control rats. Glycine-dependent [3H]MK-801 binding (functional binding under non-equilibrium conditions at a fixed L-glutamate concentration) revealed that a decreased ability of glycine to stimulate channel opening in aged rats was partially attenuated by the long-term memantine treatment. Furthermore, an increased ability of spermidine to enhance [3H]MK-801 binding in aged-control rats was even more pronounced in the aged memantine-treated group. Together these findings may indicate that changes in functional receptor-channel properties during the process of aging occur prior to a detectable loss of binding sites and that memantine enhances an endogenous compensatory mechanism triggered by glutamatergic hypofunction which is suggested to take place in aging.
Similar content being viewed by others
References
Berger ML, Seifriz I, Hornykiewicz O (1992) Inhibition of the NMDA receptor complex by memantine: involvement of the polyamine regulatory site. 15th Annunal Meeting of the European Neuroscience Association: 2188
Bormann J (1989) Memantine is a potent blocker of N-methyl-D-aspartate (NMDA) receptor channels. Eur J Pharmacol 166: 591–592
Chen HSV, Pellegrini JW, Aggarwal SK, Lei SZ, Warach S, Jensen FE, Lipton SA (1992) Open-channel block of N-Methyl-D-Aspartate (NMDA) responses by memantine —therapeutic advantage against NMDA receptor-mediated neurotoxicity. J Neurosci 12: 4427–4436
Cohen SA, Müller WE (1992) Age-related alterations of NMDA — receptor properties in the mouse forebrain — partial restoration by chronic phosphatidylserine treatment. Brain Res 584: 174–180
Cohen SA, Müller WE (1993) Effects of piracetam on N-methyl-D-aspartate receptor properties in the aged mouse brain. Pharmacology 47: 217–222
Danysz W, Archer T (1994) Glutamate, learning and dementia-selection of evidence. Amino Acids 7: 147–163
Ditzler K (1991) Efficacy and tolerability of memantine in patients with dementia syndrome. Arzneimittelforschung/Drug Res 41: 773–780
Durand GM, Gregor P, Zheng X, Bennett MVL, Uhl GR, Zukin RS (1992) Cloning of an apparent splice variant of the rat N-methyl-D-aspartate receptor NMDAR1 with altered sensitivity to polyamines and activators of protein kinase-C. Proc Natl Acad Sci USA 89: 9359–9363
Ebert B, Wong EHF, Krogsgaard-Larsen P (1991) Identification of a novel NMDA receptor in rat cerebellum. Eur J Pharmacol-Mol Pharm 208: 49–52
Erdö SL, Schäfer M (1991) Memantine is highly potent in protecting cortical cultures against excitotoxic cell death evoked by glutamate and N-methyl-D-aspartate. Eur J Pharmacol 198: 215–217
Foster AC, Wong EHF (1987) The novel anticonvulsant MK-801 binds to the activated state of the N-methyl-D-aspartate receptor in rat brain. Br J Pharmacol 91: 403–409
Görtelmeyer R, Erbler H (1992) Memantine in the treatment of mild to moderate dementia syndrome — a double-blind placebo-controlled study. Arzneimittelforschung/Drug Res 42-2: 904–913
Hartfree EF (1972) Determination of protein: a modification of the Lowry method that gives a linear photometric response. Anal Biochem 48: 422–427
Javitt DC, Zukin SR (1989) Biexponential kinetics of [3H]MK-801 binding: evidence for access to closed and open N-methyl-D-aspartate receptor channels. Mol Pharmacol 35: 387–393
Kessler M, Terramani T, Lynch G, Baudry M (1989) A glycine site associated with N-methyl-D-aspartic acid receptors: characterization and identification of a new class of antagonists. J Neurochem 52: 1319–1328
Kornhuber J, Bormann J, Retz W, Hubers M, Riederer P (1989) Memantine displaces [3H]MK-801 at therapeutic concentrations in postmortem human frontal cortex. Eur J Pharmacol 166: 589–590
Kornhuber J, Weller M, Riederer P (1993) Glutamate receptor antagonists for neuroleptic malignant syndrome and akinetic hyperthermic Parkinsonian crisis. J Neural Transm [P-D Sect] 6: 63–72
Lowry OH, Rosebrough NJ, Farr AL, Randell RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193: 265–275
Manallack DT, Lodge D, Beart PM (1989) Subchronic administration of MK-801 in the rat decreases cortical binding of [3H]D-AP5, suggesting down-regulation of the cortical N-methyl-D-aspartate receptors. Neuroscience 30: 87–94
Meldrum BS, Turski L, Schwarz M, Czuczwar SJ, Sontag K (1986) Anticonvulsant action of 1,3-dimethyl-5-aminoadamantane — Pharmacological studies in rodents and baboon, Papio Papio. Naunyn Schmiedebergs Arch Pharmacol 332: 93–97
Miyoshi R, Kito S, Doudou N, Nomoto T (1990) Age-related changes of strychnine-insensitive glycine receptors in rat brain as studied by in vitro autoradiography. Synapse 6: 338–343
Pantev M, Ritter R, Görtelmeyer R (1993) Clinical and behavioural evaluation in long-term care patients with mild to moderate dementia under memantine treatment. Z Gerontopsychol Psychiatr 2: 103–117
Parsons CG, Gruner R, Rozental J, Millar J, Lodge D (1993) Patch clamp studies on the kinetics and selectivity of N-methyl-D-aspartate receptor antagonism by memantine (1-amino-3,5-dimethyladamantane). Neuropharmacology 32: 1337–1350
Pellegrini JW, Lipton SA (1993) Delayed administration of memantine prevents N-methyl-D-aspartate receptor-mediated neurotoxicity. Ann Neurol 33: 403–407
Peterson C, Cotman CW (1989) Strain-dependent decrease in glutamate binding to the N-methyl-D-aspartic acid receptor during aging. Neurosci Lett 104: 309–313
Piggott MA, Perry EK, Perry RH, Court JA (1992) [3H]MK-801 binding to the NMDA receptor complex, and its modulation in human frontal cortex during development and aging. Brain Res 588: 277–286
Procter AW, Stirling JM, Stratmann GC, Cross AJ, Bowen DM (1989a) Loss of glycine-dependent radioligand binding to the N-methyl-D-aspartate-phencyclidine receptor complex in patients with Alzheimer's disease. Neurosci Lett 101: 62–66
Procter AW, Stratmann GC, Francis PT, Lowe SL, Bertolucci PHF, Bowen DM (1991) Characterization of the glycine modulatory site of the N-methyl-D-aspartate receptor ionophore complex in human brain. J Neurochem 56: 299–310
Procter AW, Wong EHF, Stratmann GC, Lowe SL, Bowen DM (1989b) Reduced glycine stimulation of [3H]MK-801 binding in Alzheimer's disease. J Neurochem 53: 698–704
Rabey JM, Nissipeanu P, Korczyn AD (1992) Efficacy of memantine, an NMDA receptor antagonist, in the treatment of Parkinson's disease. J Neural Transm [P-D Sect] 4: 277–282
Ransom RW, Stec NL (1988) Cooperative modulation of [3H]MK-801 binding to the N-methyl-D-aspartate receptor ion-channel complex by L-glutamate, glycine, and polyamines. J Neurochem 51: 830–836
Reynolds IJ (1994) [3H]CGP 39653 binding to the agonist site of the N-methyl-D-aspartate receptor is modulated by Mg2+ and polyamines independently of the arcaine-sensitive polyamine site. J Neurochem 62: 54–62
Rogawski MA (1993) Therapeutic potential of excitatory amino acid antagonists: channel blockers and 2,3-benzodiazepines. TIPS 14: 325–331
Saransaari P, Lillrank SM, Oja SS (1993) Phencyclidine treatment in mice: effects on phencyclidine binding sites and glutamate uptake in cerebral cortex preparations. J Neural Transm [Gen Sect] 93: 47–59
Saransaari P, Oja SS (1993a) Phencyclidine-binding sites in mouse cerebral cortex during development and ageing: effects of inhibitory amino acids. Mech Ageing Dev 68: 125–136
Saransaari P, Oja SS (1993b) Strychnine-insensitive glycine binding to cerebral cortical membranes in developing and ageing mice. Mech Ageing Dev 72: 57–66
Schneider E, Fischer PA, Clemens R (1984) Effects of oral memantine on symptoms of Parkinson's disease. Dtsch Med Wochenschr 109: 987–990
Seif El, Nasr M, Peruche B, Rossberg C, Mennel HD, Krieglstein J, Share NN (1990) Neuroprotective effect of memantine demonstrated in vivo and in vitro. Eur J Pharmacol 185: 19–24
Serra M, Ghiani CA, Foddi MC, Motzo C, Biggio G (1994) NMDA receptor function is enhanced in the hippocampus of aged rats. Neurochem Res 19: 483–487
Shaw GG, Pateman AJ (1973) The regional distribution of the polyamines spermidine and spermine in brain. J Neurochem 20: 1225–1230
Steele JE, Bowen DM, Franics PT, Green AR, Cross AJ (1990) Spermidine enhancement of [3H]MK-801 binding to the NMDA receptor complex in cortical membranes. Eur J Pharmacol-Mol Pharm 189: 195–200
Tamaru M, Yoneda Y, Ogita K, Shimizu J, Nagata Y (1991) Age-related decrease of the N-methyl-D-aspartate receptor complex in the rat cerebral cortex and hippocampus. Brain Res 542: 83–90
Thompson LT, Moskal JR, Disterhoft JF (1992) Hippocampus-dependent learning facilitated by a monoclonal antibody or D-cycloserine. Nature 359: 638–641
Weissman D, Casanova MF, Kleinman JE, DeSouza EB (1991) PCP and sigma receptors in brain are not altered after repeated exposure to PCP in humans. Neuropsychopharmacology 4: 95–102
Weller M, Finielsmarlier F, Paul SM (1993) NMDA receptor-mediated glutamate toxicity of cultured cerebellar, cortical and mesencephalic neurons: neuroprotective properties of amantadine and memantine. Brain Res 613: 143–148
Wesemann W, Sturm G, Fünfgeld EW (1980) Distribution and metabolism of the potential anti-Parkinson drug memantine in the human. J Neural Transm [P-D Sect] 16: 143–148
Williams K, Hanna JL, Molinoff PB (1991) Developmental changes in the sensitivity of the N-methyl-D-aspartate receptor to polyamines. Mol Pharmacol 40: 774–782
Williams K, Romano C, Molinoff PB (1989) Effects of polyamines on the binding of [3H]MK-801 to the N-methyl-D-aspartate receptor: pharmacological evidence for the existence of polyamine recognition site. Mol Pharmacol 36: 575–581
Williams K, Zappia AM, Pritchett DB, Shen YM, Molinoff PB (1994) Sensitivity of the N-methyl-D-aspartate receptor to polyamines is controlled by NR2 subunits. Mol Pharmacol 45: 803–809
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Bresink, I., Danysz, W., Parsons, C.G. et al. Chronic treatment with the uncompetitive NMDA receptor antagonist memantine influences the polyamine and glycine binding sites of the NMDA receptor complex in aged rats. J Neural Transm Gen Sect 10, 11–26 (1995). https://doi.org/10.1007/BF02256626
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02256626